X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (241) 241
humans (231) 231
middle aged (192) 192
aged (183) 183
female (172) 172
male (169) 169
adult (168) 168
hematology (166) 166
oncology (153) 153
article (140) 140
aged, 80 and over (134) 134
treatment outcome (111) 111
leukemia, myeloid, acute - drug therapy (83) 83
leukemia (80) 80
hematology, oncology and palliative medicine (79) 79
abridged index medicus (73) 73
acute myeloid leukemia (72) 72
prognosis (70) 70
young adult (70) 70
adolescent (69) 69
cancer (68) 68
antineoplastic combined chemotherapy protocols - therapeutic use (58) 58
hemic and lymphatic diseases (54) 54
disease-free survival (53) 53
survival (52) 52
therapy (52) 52
aml (51) 51
chemotherapy (48) 48
survival analysis (46) 46
acute myeloid-leukemia (45) 45
antineoplastic agents - therapeutic use (45) 45
leukemia, myeloid, acute - genetics (45) 45
remission induction (45) 45
acute myelogenous leukemia (44) 44
research (44) 44
chronic myelogenous leukemia (41) 41
care and treatment (39) 39
mutation (39) 39
dasatinib (38) 38
leukemia, myeloid, acute - mortality (37) 37
protein kinase inhibitors - therapeutic use (36) 36
chronic myeloid leukemia (35) 35
cytarabine (34) 34
imatinib mesylate (34) 34
myelodysplastic syndrome (33) 33
myelodysplastic syndromes - drug therapy (33) 33
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (32) 32
retrospective studies (32) 32
leukemia, myeloid, acute - pathology (31) 31
patients (31) 31
risk factors (31) 31
survival rate (31) 31
myeloid leukemia (30) 30
antineoplastic combined chemotherapy protocols - adverse effects (29) 29
follow-up studies (29) 29
cytarabine - administration & dosage (28) 28
myelodysplastic syndromes (28) 28
minimal residual disease (27) 27
patient outcomes (27) 27
recurrence (27) 27
dosage and administration (26) 26
imatinib (26) 26
pyrimidines - therapeutic use (26) 26
antineoplastic agents - adverse effects (25) 25
analysis (24) 24
clinical trials (24) 24
drug administration schedule (24) 24
antineoplastic agents - administration & dosage (23) 23
drug therapy (23) 23
mutations (23) 23
fms-like tyrosine kinase 3 - genetics (22) 22
clinical trials and observations (21) 21
cytogenetics (21) 21
trial (21) 21
benzamides (20) 20
combination (20) 20
diagnosis (20) 20
kaplan-meier estimate (20) 20
risk (20) 20
stem cells (20) 20
antineoplastic combined chemotherapy protocols - administration & dosage (19) 19
apoptosis (19) 19
azacitidine (19) 19
azacitidine - analogs & derivatives (19) 19
cml (19) 19
decitabine (19) 19
leukemia, myelogenous, chronic, bcr-abl positive - mortality (19) 19
multivariate analysis (19) 19
piperazines - therapeutic use (19) 19
tyrosine (19) 19
age factors (18) 18
myelodysplastic syndromes - mortality (18) 18
pyrimidines - administration & dosage (18) 18
transplantation (18) 18
adults (17) 17
chromosome aberrations (17) 17
dose-response relationship, drug (17) 17
leukemia, myeloid, chronic-phase - drug therapy (17) 17
nilotinib (17) 17
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 07/2018, Volume 132, Issue 2, pp. 118 - 119
In this issue of Blood, Itzykson et al report on deep sequencing of 6 receptor tyrosine kinase (RTK) genes (KIT, NRAS, KRAS, FLT3, JAK2, and CBL) in samples... 
TRIAL | ACUTE MYELOID-LEUKEMIA | MUTATIONS | HEMATOLOGY | MINIMAL RESIDUAL DISEASE
Journal Article
Blood, ISSN 0006-4971, 08/2013, Volume 122, Issue 8, pp. 1334 - 1334
In this issue of Blood, Kung Sutherland et al report on the preclinical activity of SGN-CD33A, a humanized anti-CD33 antibody conjugated to a... 
HEMATOLOGY | CELLS | Animals | Humans | Benzodiazepines - chemistry | Leukemia, Myeloid, Acute - drug therapy | Drug Resistance, Neoplasm | Sialic Acid Binding Ig-like Lectin 3 - chemistry | Immunoconjugates - chemistry | Antibodies, Monoclonal, Humanized - chemistry
Journal Article
Physics of Fluids, ISSN 1070-6631, 12/2018, Volume 30, Issue 12, p. 122104
We present numerical investigation on the dynamics of drop formation from submerged orifices under the influence of an external electric field. The study is... 
JET | MANIPULATION | MECHANICS | SIMULATIONS | PHYSICS, FLUIDS & PLASMAS | CAPILLARY | Dielectric strength | Deformation | Computational fluid dynamics | Fluid | Hydrodynamic equations | Dynamic tests | Fluids | Electrical resistivity | Orifices | Permittivity | Electric fields | Electric field strength | Electric properties
Journal Article
Blood, ISSN 0006-4971, 08/2013, Volume 122, Issue 8, pp. 1334 - 1334
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2011, Volume 29, Issue 33, pp. 4417 - 4423
Purpose Outcome in acute myeloid leukemia (AML) worsens with age, at least in part because of higher treatment-related mortality (TRM) in older patients.... 
SURVIVAL | AML | TRIALS | INTENSIVE CHEMOTHERAPY | OLDER PATIENTS | ONCOLOGY | RECOMMENDATIONS | PROGNOSTIC MODELS | BLAST CLEARANCE | CYTOGENETICS | AGE | Age Factors | Humans | Middle Aged | Induction Chemotherapy | Male | Risk | Leukemia, Myeloid, Acute - mortality | Time Factors | Adolescent | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Aged | Original Reports | Hema5
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 3, pp. 392 - 397
Journal Article
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 08/2018, Volume 27, Issue 8, pp. 661 - 666
Introduction: Acute myeloid leukemia (AML) is the most common myeloid malignancy in adults. Despite recent discoveries of targeted therapies, the frontline... 
acute myeloid leukemia | DNA damage repair pathway | cell cycle inhibitors | CHK1 inhibitor | HDAC INHIBITORS | CYTOSINE-ARABINOSIDE | CELLS | PHASE-II | PRECLINICAL DEVELOPMENT | COMBINATION | UCN-01 | DNA-REPLICATION | STRAND BREAKS | PHARMACOLOGY & PHARMACY | CHECKPOINT
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 3, pp. 398 - 404
Journal Article
Faraday Discussions, ISSN 1359-6640, 9/2018, Volume 29, pp. 259 - 271
We investigate the influence of an applied electric field on the separation of a water-ethanol solution inside a carbon nanotube (CNT) using a series of... 
Water chemistry | Separation | Ethanol | Dipoles | Graphene | Nanotubes | Carbon nanotubes | Molecular dynamics | Electric fields | Hydrogen bonding
Journal Article
EXPERT REVIEW OF HEMATOLOGY, ISSN 1747-4086, 08/2019, Volume 12, Issue 8, pp. 621 - 640
Introduction: Mutations in the gene encoding for the FMS-like tyrosine kinase 3 (FLT3) are present in about 30% of adults with AML and are associated with... 
INTERNAL TANDEM DUPLICATION | Relapsed | COMBINATION THERAPY | ACQUIRED-RESISTANCE | SALVAGE CHEMOTHERAPY | refractory acute myeloid leukemia | FLT3 inhibitors | FLT3 mutated | novel targeted therapies | MIDOSTAURIN PKC412 | TYROSINE KINASE INHIBITOR | PROGNOSTIC-SIGNIFICANCE | STEM-CELL TRANSPLANTATION | PATIENTS PTS | HEMATOLOGY | PHASE-I
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 04/2015, Volume 90, Issue 4, pp. 276 - 281
Journal Article
Faraday Discussions, ISSN 1359-6640, 2018, Volume 209, pp. 259 - 271
We investigate the influence of an applied electric field on the separation of a water-ethanol solution inside a carbon nanotube (CNT) using a series of... 
INTERMOLECULAR POTENTIAL FUNCTIONS | MOLECULAR-DYNAMICS | TRANSPORT | CHEMISTRY, PHYSICAL | DESALINATION | SIMULATION | TRENDS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.